Tess V Clendenen

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. pmc Genetic variants in hormone-related genes and risk of breast cancer
    Tess Clendenen
    Department of Population Health, New York University School of Medicine, New York, New York, United States of America
    PLoS ONE 8:e69367. 2013
  2. doi request reprint Comparison of 3-point Dixon imaging and fuzzy C-means clustering methods for breast density measurement
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Division of Epidemiology, New York, NY 10016, USA
    J Magn Reson Imaging 38:474-81. 2013
  3. pmc Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
  4. doi request reprint Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Divison of Epidemiology, New York, NY 10016, USA
    Magn Reson Imaging 31:1-9. 2013
  5. pmc Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
  6. pmc Circulating inflammation markers and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cancer Epidemiol Biomarkers Prev 20:799-810. 2011
  7. pmc Temporal reliability of cytokines and growth factors in EDTA plasma
    Tess V Clendenen
    Department of Environmental Medicine, New York University Langone Medical Center, New York, NY, USA
    BMC Res Notes 3:302. 2010
  8. pmc Circulating vitamin d and risk of epithelial ovarian cancer
    Alan A Arslan
    Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Oncol 2009:672492. 2009
  9. pmc Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle
    Alana R Amarosa
    Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, 660 First Ave, 4th Floor, New York, NY 10016, USA
    Radiology 268:356-65. 2013
  10. pmc Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer
    Tess V Clendenen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
    Cancer Epidemiol Biomarkers Prev 18:275-81. 2009

Detail Information

Publications12

  1. pmc Genetic variants in hormone-related genes and risk of breast cancer
    Tess Clendenen
    Department of Population Health, New York University School of Medicine, New York, New York, United States of America
    PLoS ONE 8:e69367. 2013
    ..Our results suggest that these genetic variants do not have a strong effect on breast cancer risk. ..
  2. doi request reprint Comparison of 3-point Dixon imaging and fuzzy C-means clustering methods for breast density measurement
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Division of Epidemiology, New York, NY 10016, USA
    J Magn Reson Imaging 38:474-81. 2013
    ..To assess two methods of fat and fibroglandular tissue (FGT) segmentation for measuring breast MRI FGT volume and FGT%, the volume percentage of FGT in the breast, in longitudinal studies...
  3. pmc Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
    ..Indirect evidence from experimental and epidemiological studies suggests that prolactin may be involved in ovarian cancer development. However, the relationship between circulating prolactin levels and risk of ovarian cancer is unknown...
  4. doi request reprint Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Divison of Epidemiology, New York, NY 10016, USA
    Magn Reson Imaging 31:1-9. 2013
    ..We conducted a pilot study to identify whether MRI parameters are sensitive to hormone-induced changes in the breast during the natural menstrual cycle and whether changes could also be observed during an oral contraceptive (OC) cycle...
  5. pmc Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
    ..Our findings suggest that risk factors for chronic diseases (age, BMI, menopausal status, parity, NSAID use, family history of breast and ovarian cancer, and smoking) are associated with inflammation markers in healthy women...
  6. pmc Circulating inflammation markers and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cancer Epidemiol Biomarkers Prev 20:799-810. 2011
    ..The purpose of this study was to assess the association between circulating levels of inflammation mediators and subsequent risk of ovarian cancer...
  7. pmc Temporal reliability of cytokines and growth factors in EDTA plasma
    Tess V Clendenen
    Department of Environmental Medicine, New York University Langone Medical Center, New York, NY, USA
    BMC Res Notes 3:302. 2010
    ..Cytokines are involved in the development of chronic diseases, including cancer. It is important to evaluate the temporal reproducibility of cytokines in plasma prior to conducting epidemiologic studies utilizing these markers...
  8. pmc Circulating vitamin d and risk of epithelial ovarian cancer
    Alan A Arslan
    Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Oncol 2009:672492. 2009
    ..59-2.01). In addition, there was no evidence of an interaction effect between VDR SNP genotype or haplotype and circulating 25(OH)D levels in relation to ovarian cancer risk, although more complex gene-environment interactions may exist...
  9. pmc Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle
    Alana R Amarosa
    Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, 660 First Ave, 4th Floor, New York, NY 10016, USA
    Radiology 268:356-65. 2013
    ....
  10. pmc Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer
    Tess V Clendenen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
    Cancer Epidemiol Biomarkers Prev 18:275-81. 2009
    ..Our results suggest that endogenous estrone is associated with increased risk of colorectal cancer in postmenopausal women...
  11. pmc Estimation and selection of complex covariate effects in pooled nested case-control studies with heterogeneity
    Mengling Liu
    Departments of Population Health and Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Biostatistics 14:682-94. 2013
    ..We conduct simulation studies to evaluate the performance of our proposed approaches in finite samples under various heterogeneity settings, and apply them to the pooled ovarian cancer study...
  12. pmc Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Cancer Lett 260:209-15. 2008
    ..These observations do not support a role for BSMI, APAI, TAQI, and FOKI polymorphisms in epithelial ovarian cancer in a predominantly Caucasian population...